Cancer Detection and Diagnosis Research in New Hampshire
Cancer Detection and Diagnosis Research (93.394) awarded $22.9 million to recipients in New Hampshire in 17 grants from fiscal 2021 to 2025, 0.9% of the program's national total. Trustees of Dartmouth College received the most, $15.0 million.
- Awarded in New Hampshire$22.9 million
- Awards17
- Share of the program0.9%
- Rank among states23rd of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 11 | $5.4 million |
| FY 2022 | 10 | $6.0 million |
| FY 2023 | 7 | $4.1 million |
| FY 2024 | 8 | $4.3 million |
| FY 2025 | 6 | $3.1 million |
Recipients in New Hampshire
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Trustees of Dartmouth College | Colleges and universities | 10 | $15.0 million |
| Xemed LLC | Small businesses | 1 | $2.7 million |
| Doseoptics LLC | Small businesses | 3 | $2.6 million |
| Insight Surgical Technologies Inc. | Small businesses | 1 | $2.1 million |
| Dartmouth-Hitchcock Clinic | Nonprofits | 2 | $459,829 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 50 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to New Hampshire?
$22.9 million from fiscal 2021 to 2025, across 17 awards. New Hampshire ranks 23rd of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in New Hampshire?
The largest recipient is Trustees of Dartmouth College, with $15.0 million in 10 awards. Next are Xemed LLC and Doseoptics LLC.
Can organizations in New Hampshire apply now?
Yes, 50 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in New Hampshire
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Special Education Grants to States
- Children's Health Insurance Program
- Drinking Water State Revolving Fund
- Title I Grants to Local Educational Agencies
- National School Lunch Program
- Low-Income Home Energy Assistance